Evidence map›Paper›PMID 23377202›Full record

ArticleNature immunology2013

Distinct TCR signaling pathways drive proliferation and cytokine production in T cells.

Clifford S Guy, Kate M Vignali, Jamshid Temirov, Matthew L Bettini, Abigail E Overacre, Matthew Smeltzer, Hui Zhang, Johannes B Huppa, Yu-Hwai Tsai, Camille Lobry and 6 more

Abstract read
In one paragraph

Article in Nature immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 221 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Parallel reactions on a single T cell receptor offer a robust kinetic proofreading mechanism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The CD8Immunity · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Clifford S GuyDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Kate M Vignali
Jamshid Temirov
Matthew L Bettini
Abigail E Overacre
Matthew Smeltzer
Hui Zhang
Johannes B Huppa
Yu-Hwai Tsai
Camille Lobry
Jianming Xie
Peter J Dempsey
Howard C Crawford
Iannis Aifantis
Mark M Davis
Dario A A Vignali
St. Jude Children's Research Hospital · USHoward Hughes Medical Institute · USNew York University · USUniversity of Michigan–Ann Arbor · USMayo Clinic · USMedical University of Vienna · AT

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Molecular Control of TCR Signaling and FunctionR01AI052199 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VIGNALI, DARIO AA · 2003 to 2015
$3.8M
T CELL RECEPTOR STRUCTURE AND EXPRESSIONR01AI022511 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 1985 to 2014
$3.3M
Mechanisms of T cell leukemia induction and maintenanceR01CA149655 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2010 to 2015
$2.0M
ADAM17 in pancreatic cancer and pancreatitisR01CA159222 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRAWFORD, HOWARD C. · 2011 to 2015
$1.9M
ADAM10 in Intestinal Homeostasis and RegenerationR01DK093697 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEMPSEY, PETER J · 2012 to 2016
$1.5M
Pancreatic Tumor Progression in the Absence of ADAM-mediated alpha-secretase ActiR03CA129579 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI CRAWFORD, HOWARD C. · 2007 to 2008
$155k
Howard Hughes Medical InstituteNCI NIH HHS CA21765NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA149655NCI NIH HHS R01 CA159222NCI NIH HHS R03 CA129579NIAID NIH HHS R01 AI022511NIAID NIH HHS R01 AI052199NIDDK NIH HHS R01 DK093697
6 · The paper itself

Abstract

The physiological basis and mechanistic requirements for a large number of functional immunoreceptor tyrosine-based activation motifs (ITAMs; high ITAM multiplicity) in the complex of the T cell antigen receptor (TCR) and the invariant signaling protein CD3 remain obscure. Here we found that whereas a low multiplicity of TCR-CD3 ITAMs was sufficient to engage canonical TCR-induced signaling events that led to cytokine secretion, a high multiplicity of TCR-CD3 ITAMs was required for TCR-driven proliferation. This was dependent on the formation of compact immunological synapses, interaction of the adaptor Vav1 with phosphorylated CD3 ITAMs to mediate the recruitment and activation of the oncogenic transcription factor Notch1 and, ultimately, proliferation induced by the cell-cycle regulator c-Myc. Analogous mechanistic events were also needed to drive proliferation in response to weak peptide agonists. Thus, the TCR-driven pathways that initiate cytokine secretion and proliferation are separable and are coordinated by the multiplicity of phosphorylated ITAMs in TCR-CD3.

Indexed as

AnimalsCD3 ComplexCell LineCell ProliferationCytokinesHEK293 CellsHumansImmunoreceptor Tyrosine-Based Activation MotifLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutPhosphorylationProto-Oncogene Proteins c-mycProto-Oncogene Proteins c-vavReceptor, Notch1CD3 ComplexCytokinesMyc protein, mouseNotch1 protein, mouseProto-Oncogene Proteins c-mycProto-Oncogene Proteins c-vavReceptor, Notch1Receptors, Antigen, T-CellVav1 protein, mouse

Identifiers

PMID23377202
PMCPMC3577985
OpenAlexW2022480304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.